COR - Insider Decision: Walgreens Boots Alliance Inc Offloads $991.64M Worth Of Cencora Stock | Benzinga
Walgreens Boots Alliance Inc, 10% Owner at Cencora (NYSE:COR), executed a substantial insider sell on February 9, according to an SEC filing.
What Happened: Inc's decision to sell 4,212,395 shares of Cencora was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Friday. The total value of the sale is $991,639,906.
During Friday's morning session, Cencora shares down by 0.0%, currently priced at $230.32.
Delving into Cencora's Background
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Cencora's Economic Impact: An Analysis
Revenue Growth: Cencora's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 14.97%. This indicates a substantial increase in the company's ...